Company Filing History:
Years Active: 2014-2017
Title: Georg Horstick: Innovator in Pharmaceutical Chemistry
Introduction
Georg Horstick is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds that have therapeutic applications.
Latest Patents
Horstick holds 5 patents, with his latest inventions focusing on 3-heteroaroylamino-propionic acid derivatives. These compounds are recognized for their potential as valuable pharmaceutical active agents. They serve as inhibitors of the protease cathepsin A, which is crucial in treating various diseases, including atherosclerosis, heart failure, renal diseases, liver diseases, and inflammatory conditions. The patents also detail processes for the preparation of these compounds and their use in pharmaceutical compositions.
Career Highlights
Georg Horstick is currently associated with Sanofi, a leading global healthcare company. His work at Sanofi emphasizes the importance of innovation in developing new therapeutic solutions that address critical health challenges.
Collaborations
Throughout his career, Horstick has collaborated with esteemed colleagues such as Sven Ruf and Thorsten Sadowski. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Georg Horstick's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in medical treatments and therapies.